Ocrelizumab (OCREVUS™), an anti-B cell therapy has been approved by the FDA as of March 28th 2017, for the treatment of Relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS). This treatment is highly effective for RRMS, based on the data from the Phase III...
Tisch MS Research Center of New York (Tisch MSRCNY) will hold its' 20th Annual MS Patient Education Symposium on Sunday, October 22nd at the New York Hilton in Midtown. The doors open at 8:30am and the program will be from 9:30am to 1:00pm. To register please visit: www.tischms.org/events We are...
We are just days away from the 20th Annual Tisch MS Research Center Patient Education Symposium. Don't miss this free event open to all people with MS, their family, friends and caregivers. Register at: www.tischms.org/events
Thank you to those of you who attended the 2017 Tisch MSRCNY Patient Symposium. We are happy to provide above, the citrus butter salmon recipe featured in Dr. Bates' presentation, Recipe for Success!
Thank you for attending the 20th Annual Tisch MS Patient Symposium. Your opinion is important to us and helps us plan next year's event. Please take a moment to complete our survey by clicking on the image below:
Oct. 25th-28th, 2017 – Tisch MSRCNY researchers travel to Paris, France to attend the 2017 joint ECTRIMS-ACTRIMS meeting. This week, five of Tisch MSRCNY’s researchers are in Paris, France to attend the 7 th ever joint ECTRIMS-ACTRIMS meeting. Eight abstracts from our Tisch MSRCNY researchers will...
Catch up with Dr. Sadiq and his patient Aoife Kirwan as she interviews him about our recent advances in stem cell research at the 2017 ECTRIMS-ACTRIMS conference in Paris, France. Aoife lives in Ireland, and is an active blogger and advocate for patients with MS. Please click the links below to...
Our deepest gratitude to all of our supporters including, U.S. Senator Charles E. Schumer who spoke at the event. “The Tisch MS Research Center is the ONLY place in the country with an FDA-approved Phase II stem cell clinical trial for MS,” said Senator Schumer. “The innovative research that Dr...